Summary

This document outlines critical guidelines for adhering to strict ethical and legal standards within the pharmaceutical industry, focusing heavily on safeguarding patient safety and bodily integrity. Key measures involve prohibiting any financial gains by living or deceased donors for the benefit of recipients, which underscores a commitment to integrity and transparency. The guidance emphasizes the necessity of rigorous biological standardization to ensure that pharmaceuticals are safe, effective, and free from adverse effects. It also details efforts to prevent falsification and manage shortages by maintaining high standards of quality and efficacy. Furthermore, the regulations cover specific EDQM initiatives designed to address critical medicines and borderline products, ensuring continuous monitoring of the drug supply chain. The final section highlights the ongoing efforts to classify medicines effectively for various regions and support programs, ensuring the highest potential for medical outcomes while strictly enforcing the prohibition of financial gain linked to human tissue.

Title

European Directorate for the Quality of Medicines and Healthcare - European Directorate for the Quality of Medicines & HealthCare

Description

The EDQM is a leading organisation that protects public health by: enabling the development, supporting the implementation and monitoring the application of quality standards for safe medicines and their safe use which are recognised as a scientific benc

Keywords

back, european, contact, medicines, programme, helpdesk, human, blood, newsroom, reference, standards, cosmetics, quality, testing, activities, products, food

NS Lookup

A 193.164.228.50

Dates

Created 2026-03-08

Updated 2026-04-13

Summarized 2026-04-13